LSL Stock Overview
LSL Pharma Group Inc. engages in the development, manufacture, and distribution of natural health products and dietary supplements in solid dosage forms and sterile ophthalmic pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LSL Pharma Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.41 |
| 52 Week High | CA$0.64 |
| 52 Week Low | CA$0.35 |
| Beta | 0 |
| 1 Month Change | 2.50% |
| 3 Month Change | -18.00% |
| 1 Year Change | -26.79% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -45.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| LSL | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | -3.5% | -1.9% | -2.1% |
| 1Y | -26.8% | -12.9% | 3.6% |
Return vs Industry: LSL underperformed the Canadian Personal Products industry which returned -12.7% over the past year.
Return vs Market: LSL underperformed the Canadian Market which returned 3.2% over the past year.
Price Volatility
| LSL volatility | |
|---|---|
| LSL Average Weekly Movement | 8.7% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: LSL's share price has been volatile over the past 3 months.
Volatility Over Time: LSL's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Francois Roberge | www.laboratoirelsl.com |
LSL Pharma Group Inc. engages in the development, manufacture, and distribution of natural health products and dietary supplements in solid dosage forms and sterile ophthalmic pharmaceutical products. The company is based in Boucherville, Canada.
LSL Pharma Group Inc. Fundamentals Summary
| LSL fundamental statistics | |
|---|---|
| Market cap | CA$40.39m |
| Earnings (TTM) | -CA$11.01m |
| Revenue (TTM) | CA$8.86m |
4.6x
P/S Ratio-3.7x
P/E RatioIs LSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSL income statement (TTM) | |
|---|---|
| Revenue | CA$8.86m |
| Cost of Revenue | CA$8.55m |
| Gross Profit | CA$308.55k |
| Other Expenses | CA$11.32m |
| Earnings | -CA$11.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 3.48% |
| Net Profit Margin | -124.30% |
| Debt/Equity Ratio | 115.8% |
How did LSL perform over the long term?
See historical performance and comparison